Viking Global Investors
ABEO icon

Viking Global Investors’s Abeona Therapeutics ABEO Stock Holding History

Viking Global Investors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,741
Closed -$2.1M – 59
2018
Q4 		$2.1M Sell
11,741
-19,312
-62% -$4.21M 0.01% 56
2018
Q3 		$9.94M Sell
31,053
-70,977
-70% -$25.2M 0.06% 60
2018
Q2 		$40.8M Sell
102,030
-27,118
-21% -$11.9M 0.23% 51
2018
Q1 		$46.3M Sell
129,148
-32,481
-20% -$12.1M 0.28% 47
2017
Q4 		$64M Buy
161,629
+72,080
+80% +$29.8M 0.39% 41
2017
Q3 		$38.2M Buy
+89,549
New +$24.1M 0.25% 53

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Viking Global Investors's ABEO Position: Q1 2019 in Review

Viking Global Investors sold out of Abeona Therapeutics (ABEO) in Q1 2019, closing a stake of 11,741 shares — an estimated $2.1M sold.

Viking Global Investors first reported a position in ABEO in Q3 2017 and held it in 6 quarters. The position peaked at $64M in Q4 2017. 87 funds tracked by Wall St. Rank hold ABEO as of Q1 2019.

  • Viking Global Investors reported no remaining Abeona Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Viking Global Investors sold 11,741 Abeona Therapeutics shares in Q1 2019, an estimated $2.1M.
  • Viking Global Investors first reported a position in Abeona Therapeutics in Q3 2017 and held it in 6 quarters.
  • Viking Global Investors's Abeona Therapeutics position peaked at $64M in Q4 2017.
  • 87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2019.

Based on Viking Global Investors's 13F filing for Q1 2019, filed 15 May 2019.